Hormonal receptor & HER2 status | Pathological stage | ||
---|---|---|---|
Stage II | Stage III | Total | |
ER | |||
 positive | 5(29.4%) | 12(70.6%) | 17(100%) |
 Negative | 1(5.9%) | 16(94.1%) | 17(100%) |
0.071944 | 6 | 28 | 34(100%) |
PR | |||
 Positive | 4(40.0%) | 6(60.0%) | 10(100%) |
 Negative | 2(8.3%) | 22(91.7%) | 24(100%) |
P-value 0.027317 | 6 | 28 | 34(100%) |
HER2 | |||
 positive | 0(0%) | 3(100%) | 3(100%) |
 Negative | 6(20.7%) | 23(79.3%) | 29(100%) |
P-value 0.249442 | 6 | 26 | 32(100%) |